Skip to main content

Table 1 Overview of the number of animals, age at inclusion, sex and weight at vaccination or injection, per treatment group

From: A field efficacy and safety trial in the Netherlands in pigs vaccinated at 3 weeks of age with a ready-to-use porcine circovirus type 2 and Mycoplasma hyopneumoniae combined vaccine

  Control (N = 276) FLEX (N = 267) PCVM (N = 269) Overall (N = 812)
Age (days)
 16 3 (1.1%) 3 (1.1%) 2 (0.7%) 8 (1.0%)
 17 39 (14.1%) 35 (13.1%) 40 (14.9%) 114 (14.0%)
 18 44 (15.9%) 42 (15.7%) 43 (16.0%) 129 (15.9%)
 19 28 (10.1%) 27 (10.1%) 28 (10.4%) 83 (10.2%)
 20 3 (1.1%) 3 (1.1%) 3 (1.1%) 9 (1.1%)
 21 15 (5.4%) 16 (6.0%) 14 (5.2%) 45 (5.5%)
 22 26 (9.4%) 25 (9.4%) 27 (10.0%) 78 (9.6%)
 23 61 (22.1%) 58 (21.7%) 60 (22.3%) 179 (22.0%)
 24 32 (11.6%) 33 (12.4%) 27 (10.0%) 92 (11.3%)
 25 22 (8.0%) 22 (8.2%) 22 (8.2%) 66 (8.1%)
 26 3 (1.1%) 3 (1.1%) 3 (1.1%) 9 (1.1%)
Gender
 Female 144 (52.2%) 136 (50.9%) 122 (45.4%) 402 (49.5%)
 Male 132 (47.8%) 131 (49.1%) 147 (54.6%) 410 (50.5%)
Weight (kg)
 N 276 267 269 812
 Mean 5.6 5.6 5.7 5.6
 Standard deviation 1.54 1.56 1.57 1.56
 Minimum 1.6 1.7 1.9 1.6
 Maximum 10.2 10.2 10.0 10.2